Greenlight Capital TEVA-OLD trades
David Einhorn
David Einhorn Teva Pharma Industries Ltd ADR stake
total: 357
Trades details
- Total transactions:
- 8
- New positions:
- 1
- Added:
- 4
- Reduced:
- 3
- Held since:
- 2023 Q4
- Held for:
- 11 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, David Einhorn holds 2,886,059 Teva Pharma Industries Ltd ADR (TEVA-OLD) shares with a market value of roughly $97.78M accounting for 2.50% of the overall portfolio. To date, the estimated cost basis is nearly $16.44 for "buy" trades and estimated average "sell" price is $31.1. Greenlight Capital first purchased TEVA-OLD in 2023 Q4, initially acquiring 268,470 shares. Since the initial investment in Teva Pharma Industries Ltd ADR (TEVA-OLD), Greenlight Capital has made 7 more transactions.
When did David Einhorn buy Teva Pharma Industries Ltd ADR (TEVA-OLD)?
David Einhorn first invested in Teva Pharma Industries Ltd ADR (TEVA-OLD) in 2023 Q4 at the reported quarter-end price of $10.44 per share.
What's the cost basis of Greenlight Capital's TEVA-OLD stake?
The estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA-OLD) stake is around $16.44 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $16.44
- Weighted AVG sell price:
- $31.10
David Einhorn's historical trades in Teva Pharma Industries Ltd ADR
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
2.50%
|
2,886,059
|
$33.88
|
$97,779,679
|
-0.85% (-24,670)
|
-0.03%
|
|
2026 Q1
|
2.75%
|
2,910,729
|
$30.12
|
$87,671,158
|
-4.84% (-148,005)
|
-0.16%
|
|
2025 Q4
|
3.35%
|
3,058,734
|
$31.21
|
$95,463,088
|
-19.05% (-720,043)
|
-0.88%
|
|
2025 Q2
|
2.72%
|
3,778,777
|
$16.76
|
$63,332,302
|
+565.04% (+3,210,577)
|
+2.31%
|
|
2025 Q1
|
0.44%
|
568,200
|
$15.37
|
$8,733,234
|
+21.27% (+99,650)
|
+0.08%
|
|
2024 Q4
|
0.53%
|
468,550
|
$22.04
|
$10,326,842
|
+44.24% (+143,700)
|
+0.16%
|
|
2024 Q1
|
0.21%
|
324,850
|
$14.11
|
$4,583,634
|
+21.00% (+56,380)
|
+0.04%
|
|
2023 Q4
|
0.14%
|
268,470
|
$10.44
|
$2,802,826
|
new
|
+0.14%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.